GAITHERSBURG, Md., April 1, 2009 — QIAGEN Gaithersburg Inc. (formerly Digene Corporation), a wholly-owned subsidiary of QIAGEN N.V. (NasdaqGS:QGEN – News) (Frankfurt:QIA.F – News) today announced the U.S. Court of Appeals for the Federal Circuit (CAFC) denied an appeal by ThirdWave Technologies Inc. (“ThirdWave’), a wholly-owned subsidiary of Hologic, Inc. (NasdaqGS:HOLX – News) and affirmed […]
QIAGEN donates one million tests to expand access to HPV screening in the world’s poorest countries Venlo, The Netherlands – April 1, 2009 – Results from an eight-year trial involving more than 130,000 women published today in The New England Journal of Medicine (NEJM) demonstrate that in low-resource settings a single round of HPV testing […]
Consensus Guideline Reached For Quantitative Polymerase Chain Reaction SALT LAKE CITY, March 31 — ARUP Laboratories and the American Association for Clinical Chemistry (AACC) announced today that a consensus guideline for a key laboratory method called qPCR (or quantitative polymerase chain reaction) was published by a group of international scientists representing the medical and research […]
ROCKVILLE, MD and ANTRIM, UNITED KINGDOM–(March 31, 2009) – Seegene, Inc. and Randox Laboratories today announced that they have entered into an agreement in which Randox will obtain a non-exclusive license to Seegene’s Dual Priming Oligo (DPO™) technology to develop high-throughput diagnostic screening panels capable of simultaneously detecting a wide variety of infectious pathogens that […]
SUNNYVALE, California, March 31 — Cepheid (Nasdaq: CPHD – News) today announced the release of the Xpert® MRSA/SA Nasal test as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. The test is designed for the simultaneous detection of nasal carriage of both Methicillin-resistant Staphylococcus aureus (MRSA) and […]
TEMPE, Ariz., March 31 — Intrinsic Bioprobes, Inc. today announced the start of a contract with the National Cancer Institute to develop effective technologies for accurate measurement of cancer-related proteins and peptides that improve diagnostic capabilities by effectively discerning diseased from non-diseased states. The total cost of the two-and-a-half-year contract is $1,276,360, out of which […]
Frontier Grid Platform Powers inSçquio Sequence Design Studio to Provide Breakthrough CAD Capabilities for Nano-engineered Products RESTON, Va.–Parabon Computation, a veteran provider of extreme-scale grid computing software and services, announced today the spin-off of Parabon NanoLabs, a subsidiary dedicated to designing and producing breakthrough products at the nano-scale. The company will initially focus on developing […]
MUKILTEO, Wash., March 30, 2009 — CombiMatrix Corporation (NasdaqGM:CBMX – News) announced today that the Agency for Health Protection and Promotion in Ontario, Canada has, during the 2007-2008 influenza season, verified the function of CombiMatrix’s Influenza-Detection system. In the study, the CombiMatrix system achieved 95.2% sensitivity and 100% selectivity, and it was stated, “In conclusion […]
Test aiding diagnosis of mental retardation, birth defects, and autism spectrum and developmental disorders now approved for use on patients in New York MADISON, N.J., March 17 — Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic testing, information and services, today announced that its ClariSure(TM) microarray-based comparative genomic hybridization (aCGH) postnatal test […]
JENA, Germany–SIRS-Lab announced today that Dr Stefan Russwurm has been asked to step down as CEO of SIRS-Lab GmbH with immediate effect. The ad interim operational responsibility of the company has been taken over by Nicolas Fulpius and Katrin Uschmann, former members of the Board of SIRS-Lab since 2007. With a strong and fully committed […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
